ArriVent BioPharma Debt/Equity Ratio 2022-2024 | AVBP

ArriVent BioPharma debt/equity ratio from 2022 to 2024. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

ArriVent BioPharma Debt/Equity Ratio 2022-2024 | AVBP

ArriVent BioPharma debt/equity ratio from 2022 to 2024. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.